Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154658 · ClinicalTrials.gov registry record · Phase 4
Serratus Anterior Plane Block in Patients Undergoing Mastectomy
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT03154658 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT03154658, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a randomized, interventional prospective study. Patients (n=66) undergoing mastectomies with or without tissue expander will be randomized to receive a supra-serratus or sub-serratus regional plane block prior to surgery. The main effect to be measured is total opioid consumption 24 hours after the operation. Secondary endpoints include measuring a change between pre-and post-operative pain scores, patient satisfaction of pain control during first 24 hours after the operation, presence of postoperative nausea and vomiting, duration of sleep on first postoperative night, and block performance time and length of stay, between the two treatment arms.
Interventions
- DRUG Ropivacaine 0.35%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2020-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154658
The ClinicalTrials.gov registry entry for NCT03154658 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ropivacaine 0.35% is the first listed.
NCT03154658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03154658 about?
NCT03154658 is a clinical study titled "Serratus Anterior Plane Block in Patients Undergoing Mastectomy". This is a randomized, interventional prospective study. Patients (n=66) undergoing mastectomies with or without tissue expander will be randomized to receive a supra-serratus or sub-serratus regional plane block prior to surgery. The main effect to be measured is total opioid consumption 24 hours af...
What is the current status of trial NCT03154658?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2017-04-01. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT03154658?
The interventions under investigation include: Ropivacaine 0.35% (DRUG).
Who is sponsoring clinical trial NCT03154658?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.